Oncolytics Biotech Inc. (ONCY)
ONCY trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.4900
+3.53% on the day
Market cap
$64.2M
Micro cap
Revenue
No annual revenue filed since the period ending 2021-12-31
Net income
No annual revenue filed since the period ending 2021-12-31
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | ONCY on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | Canada |
| IPO year | Not reported by the screener |
| SEC CIK | 0001129928 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | NV |
Financials
No annual revenue filed since the period ending 2021-12-31.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-04-06 |
| Latest annual report | 10-K | 2026-03-30 |
| Latest quarterly / interim | 10-Q | 2026-08-12 |
| Latest current report | 8-K | 2026-10-14 |
| Latest proxy | DEFA14A | 2026-10-06 |
Source: SEC EDGAR submissions feed, 1,001 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| SDEV | Stablecoin Development Corporation | $1.25 | -11.35% | $64.7M |
| FBIO | Fortress Biotech Inc. | $1.95 | -7.58% | $65.0M |
| RNTX | Rein Therapeutics Inc. | $0.7546 | -3.86% | $65.1M |
| XBIT | XBiotech Inc. | $2.16 | -5.68% | $65.9M |
| APLM | Apollomics Inc. | $21.32 | 0.00% | $61.7M |
| SPRO | Spero Therapeutics Inc. | $1.15 | -2.54% | $67.0M |
| GANX | Gain Therapeutics Inc. | $1.41 | -10.19% | $61.5M |
| VRCA | Verrica Pharmaceuticals Inc. | $3.58 | -10.72% | $61.5M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier